Physician profile
Bilal M Shafi
NPI 1306923123
$232,826.98
in general payments reported to CMS, 2019-2025
20 companies · $41K in 2025
The $41K reported for 2025 was more than what 97% of Thoracic Surgery (Cardiothoracic Vascular Surgery) providers received nationally (typical 2025 total: $796).
See the full distribution for Thoracic Surgery (Cardiothoracic Vascular Surgery)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $64K · 2020: $23K · 2021: $15K · 2022: $26K · 2023: $34K · 2024: $30K · 2025: $41K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $64K · Education: $24K · Travel and Lodging: $10K · Food and Beverage: $4,630 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $1,575.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $64,420.00 |
| Education | $24,056.35 |
| Travel and Lodging | $10,135.48 |
| Food and Beverage | $4,630.41 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $1,575.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Edwards Lifesciences Corporation | $106,773.50 | 2019-2025 | Edwards Sapien 3 Transcatheter Heart Valve (Thv), Evoque, Thruport Systems Intraclude Intra-Aortic Occlusion Device |
| W. L. Gore & Associates, INC. | $83,499.79 | 2019-2025 | Product In Development, Gore Tag Conformable Thoracic Endoprosthesis, Gore Dryseal Sheath |
| Intuitive Surgical, INC. | $34,720.09 | 2019-2025 | Da Vinci Surgical System |
| Abbott Laboratories | $3,149.50 | 2019-2025 | Triclip |
| Artivion, INC. | $2,059.47 | 2024-2025 | Cryovalve Sg Pulmonary Human Heart Valve, Cardiac Non-Synergraft, On-X Aortic Heart Valve With Conform-X Sewing Ring and Extended Holder |
| Atricure, INC. | $1,718.69 | 2019-2025 | Atriclip Laa Exclusion System, Epi-Ease Epicardial Access System, Synergy Ablation System |
| Clearflow INC. | $150.00 | 2019 | |
| Angiodynamics, INC. | $139.34 | 2019-2025 | Angiovac |
| Elutia, INC. | $103.09 | 2020 | |
| Philips North America LLC | $92.04 | 2019 | |
| Ethicon US, LLC | $89.30 | 2019-2024 | Evarrest, Prolene |
| Livanova USA, INC. | $68.08 | 2019-2021 | |
| Hemosonics LLC | $64.33 | 2021-2022 | |
| Bolton Medical INC | $47.64 | 2019-2020 | |
| Haemonetics Corporation | $43.33 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kls-Martin L.P. | $26.91 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $25.67 | 2024 | Eliquis |
| Medtronic Vascular, INC. | $25.28 | 2019 | |
| Portola Pharmaceuticals, LLC | $19.68 | 2019 | |
| Shockwave Medical, INC | $11.25 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Bilal Shafi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.